Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Scientific Reports
|
April 5, 2020
Microbial lag phase can be indicative of, or independent from, cellular stress
Philip G Hamill, Andrew Stevenson, Phillip E McMullan, et al.
Synapse (New York, N.Y.)
|
August 6, 2010
The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers
Terence G Hamill, Waisi Eng, Andrew Jennings, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
November 23, 2020
Preclinical evaluation of [<sup>11</sup> C]L-235 as a radioligand for Positron Emission Tomography cathepsin K imaging in bone
Idriss Bennacef, Daniel Rubins, Kerry Riffel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2013
(11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists
Koenraad J Van Laere, Sandra M Sanabria-Bohórquez, David P Mozley, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist
M E Duggan, L T Duong, J E Fisher, et al.
Synapse (New York, N.Y.)
|
April 2, 2005
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
Terence G Hamill, Stephen Krause, Christine Ryan, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1
Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Journal of Medicinal Chemistry
|
July 5, 2007
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use
Ping Liu, Linus S Lin, Terence G Hamill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2007
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
H Donald Burns, Koen Van Laere, Sandra Sanabria-Bohórquez, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
Ping Liu, Terence G Hamill, Marc Chioda, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Scientific Reports
|
April 5, 2020
Microbial lag phase can be indicative of, or independent from, cellular stress
Philip G Hamill, Andrew Stevenson, Phillip E McMullan, et al.
Synapse (New York, N.Y.)
|
August 6, 2010
The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers
Terence G Hamill, Waisi Eng, Andrew Jennings, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
November 23, 2020
Preclinical evaluation of [<sup>11</sup> C]L-235 as a radioligand for Positron Emission Tomography cathepsin K imaging in bone
Idriss Bennacef, Daniel Rubins, Kerry Riffel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2013
(11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists
Koenraad J Van Laere, Sandra M Sanabria-Bohórquez, David P Mozley, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist
M E Duggan, L T Duong, J E Fisher, et al.
Synapse (New York, N.Y.)
|
April 2, 2005
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
Terence G Hamill, Stephen Krause, Christine Ryan, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1
Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Journal of Medicinal Chemistry
|
July 5, 2007
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use
Ping Liu, Linus S Lin, Terence G Hamill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2007
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
H Donald Burns, Koen Van Laere, Sandra Sanabria-Bohórquez, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
Ping Liu, Terence G Hamill, Marc Chioda, et al.
Page
of 5